Arrhythmias & electrophysiologyCross-sectional study

Association of non-invasive atrial cardiomyopathy markers with cerebral stroke lesions: a population-based analysis from the Hamburg City Health Study

EuropacePublished

  • Cross-sectional study
  • population-based

Authors' conclusion

The incremental diagnostic value of AtCM markers beyond clinical risk factors for MRI-defined cerebral lesions is limited, likely reflecting the heterogeneous aetiology of stroke lesions in a general population cohort.

Study context

Population
Hamburg City Health Study participants with cerebral magnetic resonance imaging (MRI), baseline 12-lead electrocardiography (ECG) and TTE in sinus rhythm
Participants
1,794 participants
Exposure
Non-invasive atrial cardiomyopathy markers (ECG, TTE, blood biomarkers) added to clinical risk factors vs clinical risk factor model alone
Outcome
Incremental diagnostic value of atrial cardiomyopathy markers beyond clinical risk factors for stroke lesions on MRI

Main finding

Stroke lesions on MRI

ΔAUC

0.03

95% CI 0.0001–0.0594

As reported in the abstract

Stroke lesions present
152 participants (8.5%)
Independent predictor in combined model: CHA2DS2-VA score, OR per point
1.95 (95% CI 1.49-2.55, P < 0.001)
Independent predictor in combined model: P-wave area in lead II, OR per 100 µV·ms
0.99 (95% CI 0.98-1.00, P = 0.031)

Observational data: associations, not effects.

Further findings

Univariable associations with stroke lesions

Male sex, prior atrial fibrillation (AF) and higher CHA2DS2-VA score significantly associated
Atrial cardiomyopathy (AtCM) markers significant: Amplified P-wave duration (APWD), P-wave area in lead II, PR interval, LA volume index, LA EF, NT-proBNP

Original publication

Association of non-invasive atrial cardiomyopathy markers with cerebral stroke lesions: a population-based analysis from the Hamburg City Health Study. Europace. Published 27 March 2026. doi:10.1093/europace/euag063

Summarised from the published abstract; every number is checked against it